TRINITY BIOTECH Files Routine 6-K Report on March 25, 2026
Ticker: TRIB · Form: 6-K · Filed: Mar 25, 2026 · CIK: 0000888721
| Field | Detail |
|---|---|
| Company | Trinity Biotech PLC (TRIB) |
| Form Type | 6-K |
| Filed Date | Mar 25, 2026 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: regulatory-filing, foreign-issuer, routine-disclosure
TL;DR
**TRINITY BIOTECH's 6-K is a routine foreign issuer report, no big news here.**
AI Summary
TRINITY BIOTECH PLC filed a 6-K on March 25, 2026, indicating a routine report for foreign issuers. This filing, with accession number 0001178913-26-001700, includes a 6-K document, an EX-99.1 exhibit, and a graphic. For investors, this filing is a standard disclosure and doesn't reveal new financial or operational information, meaning it likely won't impact the stock price significantly.
Why It Matters
This filing is a standard disclosure for foreign companies and does not contain new material information that would typically affect investment decisions or stock performance.
Risk Assessment
Risk Level: low — The filing is a standard regulatory report and does not indicate any new financial or operational risks for the company.
Analyst Insight
Investors should recognize this as a standard regulatory update without new material information, suggesting no immediate action is required based solely on this filing. Further research into other company news or financial reports would be more impactful.
Key Numbers
- 3 — Number of Documents (The filing includes 3 documents: 6-K, EX-99.1, and a graphic.)
- 12820 — Size of 6-K document (The main 6-K document (zk2634943.htm) is 12820 bytes.)
- 17072 — Size of EX-99.1 document (The exhibit document (exhibit_99-1.htm) is 17072 bytes.)
- 94417 — Size of graphic document (The image document (image00001.jpg) is 94417 bytes.)
Key Players & Entities
- TRINITY BIOTECH PLC (company) — the filer of the 6-K report
- 0000888721 (company) — CIK of TRINITY BIOTECH PLC
- 0001178913-26-001700 (other) — SEC Accession No. for the filing
- 2026-03-25 (date) — Filing Date and Period of Report
Forward-Looking Statements
- The stock price of TRINITY BIOTECH PLC will remain stable following this routine 6-K filing. (TRINITY BIOTECH PLC) — high confidence, target: 2026-03-26
FAQ
What is the purpose of a 6-K filing for TRINITY BIOTECH PLC?
A 6-K filing is a 'Report of foreign issuer' under Rules 13a-16 and 15d-16, used by foreign private issuers like TRINITY BIOTECH PLC to report information that is material to investors and made public in their home country, or filed with a foreign stock exchange.
When was this specific 6-K filing submitted and accepted by the SEC?
This 6-K filing by TRINITY BIOTECH PLC was filed on March 25, 2026, and accepted on the same date at 09:12:34.
What documents are included in this 6-K submission?
The submission includes three documents: the main 6-K document (zk2634943.htm), an EXHIBIT 99.1 (exhibit_99-1.htm), and an image file (image00001.jpg).
What is the CIK (Central Index Key) for TRINITY BIOTECH PLC?
The CIK for TRINITY BIOTECH PLC, as stated in the filing, is 0000888721.
What is TRINITY BIOTECH PLC's primary SIC (Standard Industrial Classification) code?
TRINITY BIOTECH PLC's primary SIC code is 2835, which corresponds to 'In Vitro & In Vivo Diagnostic Substances'.
Filing Stats: 245 words · 1 min read · ~1 pages · Grade level 10.9 · Accepted 2026-03-25 09:12:34
Filing Documents
- zk2634943.htm (6-K) — 13KB
- exhibit_99-1.htm (EX-99.1) — 17KB
- image00001.jpg (GRAPHIC) — 92KB
- 0001178913-26-001700.txt ( ) — 157KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TRINITY BIOTECH PLC Trinity Biotech plc (Registrant) By: /s/ Paul Murphy Paul Murphy Interim Chief Financial Officer Date: March 25, 2026